Tularemia secondary prevention

Revision as of 14:44, 1 March 2016 by Ilan Dock (talk | contribs)
Jump to navigation Jump to search

Tularemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tularemia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Findings

Treatment

Medical Therapy

Prevention

Case Studies

Case #1

Tularemia secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tularemia secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tularemia secondary prevention

CDC on Tularemia secondary prevention

Tularemia secondary prevention in the news

Blogs on Tularemia secondary prevention

Directions to Hospitals Treating Tularemia

Risk calculators and risk factors for Tularemia secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Antibiotics, nation-wide education and programming are all used to reduce the amount of and treat individuals experiencing symptoms often associated with tularemia.

Secondary Prevention

The CDC operates a national program for bioterrorism preparedness and response that incorporates a broad range of public health partnerships. Other things CDC is doing include:

  • Stockpiling antibiotics to treat infected people
  • Coordinating a nation-wide program where states share information about tularemia
  • Creating new education tools and programs for health professionals, the public, and the media.

References

Template:WH Template:WS